Saxenda uk is prescribed for obese or overweight people who also have weight-related medical conditions in order to assist them lose weight and keep it off. Saxenda is indicated for children aged 12 to 17 years with obesity and a bodyweight greater than 132 pounds (60 kg). Saxenda is taken in conjunction with a healthy diet and regular exercise.
Saxenda is an injection given once a day under the skin (subcutaneous) from a multi-dose injection pen.
Victoza and Saxenda both contain the same active component (liraglutide). The distinction between Saxenda and Victoza is that they are of varying strengths and are FDA approved for various conditions.
Saxenda is not approved to treat type 1 or type 2 diabetes. It is unknown whether Saxenda is safe and effective in children under the age of 12. It is unknown whether Saxenda is safe and effective in youngsters with type 2 diabetes aged 12 to 17 years.
How does saxenda uk work?
Saxenda aids weight loss by suppressing appetite, decreasing stomach emptying, and making you feel fuller for longer, causing you to eat fewer calories. Saxenda functions similarly to a hormone that occurs naturally in the body and aids in the regulation of blood sugar, insulin levels, and digestion. Saxenda is a glucagon-like peptide-1 (GLP-1) agonist, which is a type of medication.
What is Saxenda used for?
Saxenda is FDA-approved for weight loss and to help you keep the weight off after you’ve lost it. It can be used for the following purposes:
- obese adults (BMI 30 kg/m2 or greater)
- overweight adults (BMI 27 kg/m2 or greater) who also have weight-related medical problems e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia.
Pediatric patients aged 12 years and older:
- body weight above 60 kg and
- their initial BMI corresponding to 30 kg/m2 or greater for adults (obese) by international cut-offs (Cole Criteria)